The Need for Clinical Guidance in the Use of Calcium and Vitamin D in the Management of Osteoporosis: a Consensus Report

Overview

Journal Osteoporos Int

Specialties Endocrinology
Orthopedics

Date 2004 Apr 8

PMID 15069595

Citations 23

Authors

S Boonen

R Rizzoli

P J Meunier

M Stone

G Nuki

U Syversen

M Lehtonen-Veromaa

P Lips

O Johnell

J-Y Reginster

Affiliations

Soon will be listed here.

Abstract

A European Union (EU) directive on vitamins and minerals used as ingredients of food supplements with a nutritional or physiological effect (2002/46/EC) was introduced in 2003. Its implications for the use of oral supplements of calcium and vitamin D in the prevention and treatment of osteoporosis were discussed at a meeting organized with the help of the World Health Organization (WHO) Collaborating Center for Public Health Aspects of Rheumatic Diseases (Liège, Belgium) and the support of the WHO Collaborating Center for Osteoporosis Prevention (Geneva, Switzerland). The following issues were addressed: Is osteoporosis a physiological or a medical condition? What is the evidence for the efficacy of calcium and vitamin D in the management of postmenopausal osteoporosis? What are the risks of self-management by patients in osteoporosis? From their discussions, the panel concluded that: (1) osteoporosis is a disease that requires continuing medical attention to ensure optimal therapeutic benefits; (2) when given in appropriate doses, calcium and vitamin D have been shown to be pharmacologically active (particularly in patients with dietary deficiencies), safe, and effective for the prevention and treatment of osteoporotic fractures; (3) calcium and vitamin D are an essential, but not sufficient, component of an integrated management strategy for the prevention and treatment of osteoporosis in patients with dietary insufficiencies, although maximal benefit in terms of fracture prevention requires the addition of antiresorptive therapy; (4) calcium and vitamin D are a cost-effective medication in the prevention and treatment of osteoporosis; (5) it is apparent that awareness of the efficacy of calcium and vitamin D in osteoporosis is still low and further work needs to be done to increase awareness among physicians, patients, and women at risk; and (6) in order that calcium and vitamin D continues to be manufactured to Good Manufacturing Practice standards and physicians and other health care professionals continue to provide guidance for the optimal use of these agents, they should continue to be classified as medicinal products.

Citing Articles

Early Screening for Confusion and Vitamin D Deficiency in Elderly Hip Fracture Patients: A Quality Improvement Initiative to Mitigate the Risk of Postoperative Delirium.

Younis Z, Gurukiran G, Abdullah F, Kumar S, Ford D, Hamid M Cureus. 2025; 16(12):e75099.

PMID: 39759656 PMC: 11698222. DOI: 10.7759/cureus.75099.

Race and ethnic differences in physical activity, osteopenia, and osteoporosis: results from NHANES 2009-2010, 2013-2014, 2017-2018.

Vasquez E, Alam M, Murillo R Arch Osteoporos. 2023; 19(1):7.

PMID: 38150070 DOI: 10.1007/s11657-023-01356-1.

Inter - Relationship of Awareness, Knowledge, Attitude, Some Socio-Economic Variables and Osteoporosis in Sample of Egyptian Women.

E Hassan N, M El Shebini S, A El-Masry S, H Ahmed N, Y El Sherity S, El Hamed E Open Access Maced J Med Sci. 2019; 7(15):2538-2544.

PMID: 31666861 PMC: 6814468. DOI: 10.3889/oamjms.2019.707.

A Resident-led Initiative Improves Screening and Treatment for Vitamin D Deficiency in Patients with Hip Fractures.

Lansdown D, Whitaker A, Wustrack R, Sawyer A, Hansen E Clin Orthop Relat Res. 2016; 475(1):264-270.

PMID: 27549989 PMC: 5174045. DOI: 10.1007/s11999-016-5036-4.

Inadequate Dietary Calcium and Vitamin D Intake in Patients with Osteoporotic Fracture.

Yoon D, Lee Y, Ha Y, Kim H J Bone Metab. 2016; 23(2):55-61.

PMID: 27294077 PMC: 4900961. DOI: 10.11005/jbm.2016.23.2.55.

References

Masud T, Mulcahy B, Thompson A, Donnelly S, Keen R, Doyle D . Effects of cyclical etidronate combined with calcitriol versus cyclical etidronate alone on spine and femoral neck bone mineral density in postmenopausal osteoporotic women. Ann Rheum Dis. 1998; 57(6):346-9. PMC: 1752624. DOI: 10.1136/ard.57.6.346. View

Koster J, HACKENG W, Mulder H . Diminished effect of etidronate in vitamin D deficient osteopenic postmenopausal women. Eur J Clin Pharmacol. 1996; 51(2):145-7. DOI: 10.1007/s002280050175. View

Valimaki M, Karkkainen M, Lamberg-Allardt C, Laitinen K, Alhava E, Heikkinen J . Exercise, smoking, and calcium intake during adolescence and early adulthood as determinants of peak bone mass. Cardiovascular Risk in Young Finns Study Group. BMJ. 1994; 309(6949):230-5. PMC: 2540782. DOI: 10.1136/bmj.309.6949.230. View

Gillespie W, Avenell A, Henry D, OConnell D, Robertson J . Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev. 2001; (1):CD000227. DOI: 10.1002/14651858.CD000227. View

Pluijm S, Dik M, Jonker C, Deeg D, Van Kamp G, Lips P . Effects of gender and age on the association of apolipoprotein E epsilon4 with bone mineral density, bone turnover and the risk of fractures in older people. Osteoporos Int. 2002; 13(9):701-9. DOI: 10.1007/s001980200096. View

Holick M . Vitamin D requirements for humans of all ages: new increased requirements for women and men 50 years and older. Osteoporos Int. 1999; 8 Suppl 2:S24-9. DOI: 10.1007/pl00022729. View

Lips P . Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001; 22(4):477-501. DOI: 10.1210/edrv.22.4.0437. View

Gold D . The clinical impact of vertebral fractures: quality of life in women with osteoporosis. Bone. 1996; 18(3 Suppl):185S-189S. DOI: 10.1016/8756-3282(95)00500-5. View

Reginster J, Deroisy R, Pirenne H, Frederick I, Dewe W, Albert A . High prevalence of low femoral bone mineral density in elderly women living in nursing homes or community-dwelling: a plausible role of increased parathyroid hormone secretion. Osteoporos Int. 1999; 9(2):121-8. DOI: 10.1007/s001980050124. View

10.

Hall S, Criddle R, Comito T, Prince R . A case-control study of quality of life and functional impairment in women with long-standing vertebral osteoporotic fracture. Osteoporos Int. 2000; 9(6):508-15. DOI: 10.1007/s001980050178. View

11.

CHAPUY M, Pamphile R, Paris E, Kempf C, Schlichting M, Arnaud S . Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int. 2002; 13(3):257-64. DOI: 10.1007/s001980200023. View

12.

Center J, Nguyen T, Schneider D, Sambrook P, Eisman J . Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet. 1999; 353(9156):878-82. DOI: 10.1016/S0140-6736(98)09075-8. View

13.

Mottonen T, Nuotio I, Irjala K, Leino A, Viikari J . Vitamin D and attainment of peak bone mass among peripubertal Finnish girls: a 3-y prospective study. Am J Clin Nutr. 2002; 76(6):1446-53. DOI: 10.1093/ajcn/76.6.1446. View

14.

Boonen S, Aerssens J, Dequeker J . Age-related endocrine deficiencies and fractures of the proximal femur. II implications of vitamin D deficiency in the elderly. J Endocrinol. 1996; 149(1):13-7. DOI: 10.1677/joe.0.1490013. View

15.

Meunier P, CHAPUY M, Arlot M, Delmas P, Duboeuf F . Can we stop bone loss and prevent hip fractures in the elderly?. Osteoporos Int. 1994; 4 Suppl 1:71-6. DOI: 10.1007/BF01623440. View

16.

Lippuner K, Von Overbeck J, Perrelet R, BOSSHARD H, Jaeger P . Incidence and direct medical costs of hospitalizations due to osteoporotic fractures in Switzerland. Osteoporos Int. 1997; 7(5):414-25. DOI: 10.1007/pl00004149. View

17.

Nieves J, Komar L, Cosman F, Lindsay R . Calcium potentiates the effect of estrogen and calcitonin on bone mass: review and analysis. Am J Clin Nutr. 1998; 67(1):18-24. DOI: 10.1093/ajcn/67.1.18. View

18.

Cranney A, Tugwell P, Wells G, Guyatt G . Meta-analyses of therapies for postmenopausal osteoporosis. I. Systematic reviews of randomized trials in osteoporosis: introduction and methodology. Endocr Rev. 2002; 23(4):496-507. DOI: 10.1210/er.2001-1002. View

19.

Sirola J, Kroger H, Sandini L, Tuppurainen M, Jurvelin J, Saarikoski S . Interaction of nutritional calcium and HRT in prevention of postmenopausal bone loss: a prospective study. Calcif Tissue Int. 2003; 72(6):659-65. DOI: 10.1007/s00223-002-2069-3. View

20.

Adachi J, Ioannidis G, Olszynski W, Brown J, Hanley D, Sebaldt R . The impact of incident vertebral and non-vertebral fractures on health related quality of life in postmenopausal women. BMC Musculoskelet Disord. 2002; 3:11. PMC: 107028. DOI: 10.1186/1471-2474-3-11. View